Markets › United States › NAS › ABUS

Arbutus Biopharma Corp

NAS:ABUSHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$4.23+0.24%At closeAt close · Tue 20 Oct · ≈ AED 15.53 · Market cap $836.9M · Next earnings Wed 11 Nov

Report	EPS est.	Actual	Surprise	Revenue est.	Revenue
Wed, 12 Aug 2026	−$0.0200	−$0.0260	−30.0%	$700K	$1.01M
Tue, 11 Aug 2026	−$0.0200	−$0.0300	−50.0%	$700K	$1.01M
Wed, 13 May 2026	−$0.0300	$0.8700	+3000.0%	$750K	$179.13M
Mon, 23 Mar 2026	−$0.0351	−$0.0100	+71.5%	$614.5K	$1.05M
Thu, 13 Nov 2025	−$0.0560	−$0.0400	+28.6%	$841K	$529K
Wed, 6 Aug 2025	−$0.0200	$0.0100	+150.0%	$1.59M	$10.74M
Wed, 14 May 2025	−$0.0900	−$0.1300	−44.4%	$2.24M	$1.76M
Thu, 27 Mar 2025	−$0.0800	−$0.0700	+12.5%	$2.26M	$1.57M